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Ras mutations, preferentially in codon 61 of the N-ras
oncogene, are common in human cutaneous melanomas.
In this study, we questioned the association between ras
mutations in primary melanomas and sun exposure. DNA
was extracted from formalin-fixed primary melanomas:
28 at chronically sun-exposed head and neck areas, 18 at
sites subject to intermittent sun exposure, and 28 from
unexposed mucosal membranes (vulva/vagina, anus/
rectum, palate). Mutations of both exons of H-, K-,
and N-ras genes were examined by polymerase chain
reaction/single-strand conformation polymorphism and
by direct nucleotide sequencing of the polymerase chain
reaction amplified exons. Thirty-two per cent of the head
and neck melanomas and 11% of the melanomas from
intermittently sun-exposed skin had N-ras codon 61
The incidence of human cutaneous melanoma is increasingworldwide, with the highest incidence reported inQueensland, Australia (MacLennan et al, 1992). Whereasthe number of cutaneous melanomas has increasedannually by 6% in Sweden over the last decades (Tho¨rn
et al, 1989), melanoma in the mucosal membranes and adjacent
unexposed glabrous skin from the vulva/vagina has decreased by
3.2% annually (Ragnarsson-Olding et al, 1993). This comparison and
epidemiologic data suggest that sunlight, presumably UV radiation, is
the main etiologic agent (Longstreth et al, 1992). Experiments with
animal models, including fish and marsupials, also demonstrate the
in vivo induction of melanoma by UV irradiation (Ley et al, 1989;
Setlow et al, 1989; Anders, 1991; Ley, 1997). The most direct effect
of UV light on skin is its interaction with the genetic material (DNA)
of cells resulting in point mutations.
Alterations in the ras proto-oncogenes are commonly found in solid
tumors of humans, including sporadic cutaneous melanomas (Bos,
1989). The three types of human ras genes, H-ras, K-ras, and N-ras,
encode GTP-binding proteins involved in key functions of signal
transduction and, thereby, in the control of cellular proliferation. Ras
activation occurs by mutations preferentially in codons 12, 13, and 61
(Barbacid, 1978). Despite great variation in early reports on ras mutation
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mutations; comparatively only 7% of the tumors from
the unexposed areas had such mutations. One vulvar
melanoma had an N-ras codon 12 mutation. No H-ras
or K-ras mutations were detected in any sample. The
frequency of N-ras exon 2 mutations in melanomas of
typically sunbathed skin was compared for the first time
with that in melanomas of areas completely protected
from sun exposure. The significantly higher frequency
(p J 0.04, chi square exact test) of these N-ras mutations
on the head and neck demonstrates their UV-light induc-
tion in a subset of melanomas explaining one of the
molecular effects of UV light in human skin. Key words:
human melanoma/mutation analysis/ras genes/UV exposure.
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frequencies in human cutaneous melanomas (Raybaud et al, 1988;
Albino et al, 1989; Shukla et al, 1989; van’t Veer et al, 1989), subsequent
studies including large numbers of patients and refined methodologies,
agree convincingly that the N-ras proto-oncogene, activated by muta-
tion of codon 61, is the predominant ras alteration in cutaneous
melanomas (Ball et al, 1994; Carr and Mackie, 1994; Platz et al, 1994,
1996; van Elsas et al, 1996). Of these tumors, nodular melanoma (NM)
is the subgroup with the highest incidence of N-ras mutations (Jafari
et al, 1995; van Elsas et al, 1996). Additionally, the expression of N-ras
p21 is increased in a large percentage of primary melanomas and
metastases (Platz et al, 1995a). A correlation between N-ras mutation
and expression and glutathione transferase Pi expression levels in
melanomas may have implications for drug resistance (Platz et al, 1995b).
Irradiation experiments in vitro on cloned human N-ras sequences
(van der Lubbe et al, 1988) as well as in vivo experiments on mice
(Pierceall et al, 1992), indicated a link between UV exposure and N-ras
activation. Later, the occurrence of ras mutations in primary human
cutaneous melanoma was found dependent on anatomical localization,
geographic distribution, and the extent of UV-light exposure (van Elsas
et al, 1996). When tumors from chronically sun-exposed body sites
were compared with tumors from intermittently and rarely exposed
sites, the incidence of ras mutation was highest in tumors on the face
and on the head. Additionally, the mutation frequency was higher in
Australian patients than in patients from northern and central Europe
(van Elsas et al, 1996).
To explore one of the mechanisms of UV-induced carcinogenesis
in greater detail, we analyzed mutations of all three ras genes in primary
human melanomas from three anatomical areas: the head and neck
area (chronic sun exposure), other skin sites (intermittent sun exposure),
and mucosal membranes with adjacent skin (complete absence of sun
exposure).
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The questions asked were these: Which ras genes are mutated and
what type of mutation can be found in melanomas from the three
anatomical areas? What is the frequency of ras mutations in these three
anatomical areas? Are the mutations identified consistent with UV-
light induction?
MATERIALS AND METHODS
Preparation of tumors Seventy-four formalin-fixed and paraffin-embedded
primary melanomas were used for this study. Of these tumors, 28 originated
from chronically sun-exposed head and neck areas (excluding the scalp), 18
from less exposed areas (i.e., the abdomen, back, and legs), and 28 from
completely unexposed areas: the vulva (covered by glabrous skin and mucosal
membrane), vagina (mucosal membrane only), anus and rectum (glabrous skin
and mucosal membrane), and palate (mucosal membrane only). The histogenetic
subtypes of these melanomas are listed in Table I.
From each paraffin bloc 4 µm and 20–40 µm thick sections were cut. The
4 µm thick sections were then stained with hematoxylin and eosin and used to
guide the dissection of tumor tissue from surrounding tissue in the 20–40 µm
thick sections. Tumor sections were deparaffinized with xylene twice, washed
with 70% ethanol twice followed by two acetone washes, and then dried.
Proteins were digested in 500 µl PK2 buffer (10 mM Tris, pH 8.3, 1 mM
ethylenediamine tetraacetic acid, 0.5% Tween-20) containing 50 µg proteinase
K per ml (Boehringer Mannheim GmbH, Mannheim, Germany) overnight at
56°C. DNA was extracted and purified with the Wizard DNA clean-up system
(Promega, Madison, WI), and dissolved in 50 µl H2O.
Polymerase chain reaction (PCR) and single-strand conformation ana-
lysis (SSCP) Two consecutive PCR were used to amplify exon 1 and 2 of
Table I. Histogenetic types of the primary melanomas in
relation to sun exposure of the anatomical site
Male, Female, All,
Anatomical site Histogenetic typea n 5 37 n 5 37 n 5 74
Sun-exposed areas, SSM 9 6 15
n 5 28 LMM 2 0 2
NM 8 2 10
unclassifiable 1 0 1
Intermittently SSM 9 1 10
sun-exposed areas, LMM 0 0 0
n 5 18 NM 4 2 6
unclassifiable 0 2 2
Unexposed areas, SSM 0 5 5
n 5 28 MLM 1 10 11
NM 0 6 6
unclassifiable 3 3 6
aSSM, superficial spreading melanoma; LMM, lentigo maligna melanoma; NM, nodular
melanoma; MLM, mucosal lentiginous melanoma.
Table II. Primers used in PCR for exons 1 and 2 of N-ras, H-ras, and K-ras
product length annealing temp
Sequence (59→39) (bp) (°C) number of cycles
N-ras exon 1 forward ATGACTGAGTACAAACTGGT 111 60 30
reverse CTCTATGGTGGGATCATATT
nested reverse ATCTACAAAGTGGTTCTGGA 90 60 20
N-ras exon 2 forward GATTCTTACAGAAAACAAGTG 157 56 30
reverse ATGACTTGCTATTATTGATGG
nested forward CAAGTGGTTATAGATGGTGA 118 60 15
nested reverse ATACACAGAGGAAGCCTTCG
H-ras exon 1 forward ATGACGGAATATAAGCTGGT 123 60 30
reverse CGCCAGGCTCACCTCTATA
nested reverse TGGTTCTGGATCAGCTGGAT 80 62 15
H-ras exon 2 forward AGGTGGTCATTGATGGGGAG 108 65 30
reverse AGGAAGCCCTCCCCGGTGCG
nested reverse CTCCCCGGTGCGCATGTACT 100 60 15
K-ras exon 1 forward ATGACTGAATATAAACTTGT 111 60 30
reverse CTCTATTGTTGGATCATATT
nested reverse TCCACAAAATGATTCTGAAT 89 60 20
K-ras exon 2 forward AAGTAGTAATTGATGGAGAA 109 60 30
reverse AGAAAGCCCTCCCCAGTCCT
nested forward GAAACCTGTCTCTTGGATAT 92 60 20
the H-, K-, and N-ras genes, with nested or seminested primers applied in the
second amplification. For the first PCR, 0.05 µg of genomic DNA was used
in a 10 µl PCR mixture. The PCR product was diluted 1/20 with H2O and
1 µl was incubated for the second PCR. Amplification was performed using a
DNA thermal cycler (Perkin Elmer, System 9600). Samples were denatured for
4 min at 94°C, incubated for 30 cycles [15–20 cycles in the second PCR (one
cycle 5 30 s at 94°C, 30 s at 56–65°C, 30 s at 72°C)], and finally extended
for 7 min at 72°C. All primers (Table II) were synthesized by Scandinavian
Gene Synthesis AB (Ko¨ping, Sweden). The use of a PCR workstation (UV
cabinet) and of aerosol-resistant pipette tips and multiple negative controls
minimized the risk of cross-contamination.
The final PCR products, labeled by incorporation of α-32P dCTP, were
denatured in denaturing buffer for 10 min at 92°C, and SSCP was carried out
on nondenaturing 7.5% acrylamide gels in the presence of 10% glycerol at
18°C, 40 W and without glycerol at 5°C, 30 W. The gel-temperature conditions
were strictly controlled by using a thermostatic circulation chamber attached
to the glass plate of the gel. Dried gels were exposed to X-ray film.
Nucleotide sequencing Sequence analysis was performed by direct sequenc-
ing of the PCR products using the fmol DNA Sequencing System (Promega).
The nested primers (Table II) were used as sequencing primers. Fragment
resolution was carried out on 10% acrylamide-urea gels at 50°C, 30 W. The
gels were soaked in a solution containing 10% methanol and 10% acetic acid,
then dried and exposed to X-ray film.
Statistical analyses The software StatXact (Cytel Software, Cambridge, MA)
was used for chi-square exact test and chi-square exact test for trend (Mehta
et al, 1984).
RESULTS
Genomic DNA from human melanomas was obtained by extraction
from dissected formalin-fixed 20–40 µm thick sections of the tumors.
PCR amplification of H-ras, K-ras, and N-ras exons 1 and 2 resulted
in fragments of the expected size, as verified by agarose gel electro-
phoresis. The PCR products were analyzed by SSCP. Fourteen of the
74 samples showed bandshifts. One sample had a bandshift for N-ras
exon 1, and 13 samples had bandshifts for N-ras exon 2. None of the
samples had H-ras or K-ras bandshifts. The relative SSCP band
intensities were equal in normal and shifted bands of N-ras exon 2 in
six samples (e.g., Fig 1a, lane 3, b), but reduced in the shifted bands
in seven samples (e.g., Fig 1a, lane 4). The latter seven samples
contained an abundance of infiltrating lymphocytes, as visible in
Fig 1(c). In contrast, one sample with an N-ras exon 1 bandshift had
a marked reduction of the wild-type SSCP band.
When samples with SSCP bandshifts were analyzed by direct
nucleotide sequencing, point mutations were clear in the N-ras
oncogene. All mutations but one were in codon 61 of exon 2. The
actual base changes are summarized in Table III and Fig 2 shows
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Figure 1. SSCP and histology examples. (a) Representative examples of
SSCP results. Lane 1, sample C5; lane 2, sample C11; lane 3, sample C13; lane
4, sample C14; lane 5, neg control. Arrows indicate wild-type band. (b)
Hematoxylin-stained section of sample C13, homogeneous tumor-cell
population. (c) Hematoxylin-stained section of sample C14, lymphocyte
infiltration among tumor cells.
representative examples of sequencing results. Of the exon 2 mutations,
nine were in melanomas from chronically sun-exposed head and neck
area, two were in skin subjected to intermittent sun exposure, and
two were from areas not exposed to sunlight (p 5 0.021, chi-square
exact test for trend). The difference in N-ras codon 61 mutations was
also significant between tumors from sun-exposed and unexposed
Table III. Summary of ras mutations, anatomical site, and
histogenetic type
Patient Anatomical Histogenetic Mutations N-ras
no. site type codon 61
C10a Ear NM CAA(Gln)→AAA(Lys)
C11 Neck SSM CAA(Gln)→CTA(Leu)
C13 Neck NM CAA(Gln)→AAA(Lys)
C14 Temple NM CAA(Gln)→CGA(Arg)
C15 Neck NM CAA(Gln)→CGA(Arg)
C32 Ear SSM CAA(Gln)→CGA(Arg)
C38 Cheek SSM CAA(Gln)→CGA(Arg)
C43 Cheek NM CAA(Gln)→CGA(Arg)
C48 Ear NM CAA(Gln)→CTA(Leu)
I4 Abdomen NM CAA(Gln)→AAA(Lys)
I14 Back SSM CAA(Gln)→AAA(Lys)
U18 Vulva Unclassifiable CAA(Gln)→CGA(Arg)
U19 Vulva NM CAA(Gln)→CGA(Arg)
Mutation
N-ras codon 12
U5 Vulva MLM GGT(Gly)→CGT(Arg)
aC, I, and U stand for chronically sun-exposed, intermittently sun-exposed, and
unexposed anatomical site.
Figure 2. Representative examples of sequencing results N-ras codon
61. (a) Wild-type CAA Gln, patient C5; (b) point mutation CTA Leu, patient
C11; (c) point mutation AAA Lys, patient C13; (d) point mutation CGA Arg,
patient C14.
areas, exclusively (p 5 0.04, chi-square exact test). A single exon 1
mutation, located in codon 12, was observed in a vulvar melanoma.
Fifty-seven of the samples that migrated normally in SSCP were also
analyzed for their nucleotide sequence, and all showed the wild-type
sequence. With respect to melanoma subtypes, eight mutations of
N-ras codon 61 were in NM, four in superficial spreading melanomas
(SSM), and one in an unclassifiable melanoma. Table IV contains data
on the distribution of N-ras mutations in relation to histogenetic
subtype and sun exposure.
Melanomas with ras mutations had a mean Breslow thickness of
3.6 mm (range, 1.2–11.9 mm), compared with melanomas without ras
mutation, which had a mean of 4.3 mm (range, 0.6–20.0 mm), not a
significant difference (independent t test, p 5 0.52). Even when
melanomas from completely unexposed areas were excluded from the
comparison, the difference was not significant between melanomas
760 JIVESKOG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Table IV. N-ras exon 2 mutations in relation to histogenetic
subtype and sun exposure
SSM NM Otherb
Ca I U C I U C I U
Melanomas 15 10 5 10 6 6 3 2 17
Mutated N-ras 3 1 0 6 1 1 0 0 1
N-ras mutation 20 10 0 60 17 17 0 0 6
frequency (%)
aC, I, and U stand for chronically sun-exposed, intermittently sun-exposed, and
unexposed anatomical site.
bLMM, MLM, and unclassifiable.
with ras mutations (mean thickness of 2.9 mm; range, 0.6–11.0 mm)
and without ras mutations (mean thickness 2.6 mm; range, 1.2–
6.6 mm) (independent t test, p 5 0.73).
DISCUSSION
Here we have combined PCR, SSCP, and nucleotide sequence analysis
to compare for the first time ras mutations in human melanomas in
UV exposed versus completely protected sites. We have found that this
combination of methods is sensitive and reproducible. An essential step
in the procedure is the dissection of tumor cells from formalin-fixed
tissues to avoid contamination by normal cells, which can dilute mutant
alleles with the wild-type and, thereby, obscure the results. The SSCP
runs were carried out using several different temperatures and glycerol
concentrations. As a result, 14 samples showed bandshifts in SSCP.
Subsequent nucleotide sequence analysis confirmed the presence of
point mutations in all 14 samples. In addition, 57 of the samples lacking
SSCP bandshifts but also analyzed by nucleotide sequencing, all
contained only the wild-type sequences. The dissection procedure, the
strictly controlled SSCP conditions, and the extensive use of nucleotide
sequence analysis minimized any possibility that mutations might have
escaped detection. The frequency of 19% N-ras mutations we found
in a total of 74 primary melanomas from 74 patients with sporadic
melanoma is in agreement with the 15% figure published in a recent
report on mutation screening of 272 melanomas tested similarly (van
Elsas et al, 1996). Earlier reports that relied largely on oligonucleotide
hybridization experiments resulted in variations of mutational frequen-
cies that may be partially explained by technical difficulties with the
assay procedures (Raybaud et al, 1988; Albino et al, 1989; Shukla et al,
1989; van’t Veer et al, 1989). Furthermore, those studies were small
and difficult to compare due to the lack of specific information like
tumor thickness or Clark’s levels or data on sun exposure.
All of the 14 ras mutations registered in the present investigation
were in the N-ras gene. Six N-ras codon 61 mutant samples had
balanced allelic band intensities, and originated from homogeneous
tumor-cell populations (Fig 1b). The seven samples with N-ras codon
61 mutations that showed reduced intensities of the shifted SSCP
bands were all from tissue sections containing large numbers of
infiltrating lymphocytes, resulting in an excess of wild-type alleles
(Fig 1c). All these 13 samples consisted of heterozygous tumor-cell
populations. In contrast the N-ras codon 12 mutant sample with a
marked intensity reduction of the wild-type SSCP band most likely
was hemizygous or homozygous for the mutant allele. The preferential
mutation of N-ras codon 61 in cutaneous melanomas has previously
been documented in several reports (Ball et al, 1994; Carr and Mackie,
1994; Platz et al, 1994; Jafari et al, 1995; van Elsas et al, 1996). Lentigo
malignant melanoma is the subtype of melanoma associated with long-
term constant sun exposure. NM and SSM, however, are more frequent
than lentigo malignant melanoma in the head and neck and other
areas. In fact only two of the 46 cutaneous tumors in this study belong
to the lentigo malignant melanoma subclass, and neither of them had
ras mutations. Eight of 22 nodular melanoma (36%) had N-ras exon
2 mutations whereas only four of 30 SSM (13%) had such mutations,
which is in accordance with previous notified results by Jafari et al
(1995) and van Elsas et al (1996). Furthermore, we found that 60% of
NM from chronically sun-exposed areas and only 17% of NM from
intermittently or unexposed areas had such mutations (Table IV).
The N-ras wild-type codon 61 CAA (Gln) contains a TT pyrimidine
doublet in the noncoding strand and is a site for formation of potential
mutagenic cyclobutane dimeres and (6–4) pyrimidine photoproducts,
as demonstrated by UV irradiation experiments in vitro (To¨rma¨nen and
Pfeifer, 1992). Furthermore the 39 nucleotide in the noncoding triplet
may be converted to a 8-oxo-deoxyguanosine by UV-light induction
(Yamamoto et al, 1992), leading to mispairing with adenosine. The
cloned N-ras gene has been mutationally activated in all three positions
of codon 61 after in vitro UV irradiation followed by transfection
experiments, resulting in CGA Arg, AAA Lys, and CTA Leu codon
(van der Lubbe et al, 1988). The N-ras codons 61 mutant triplets we
observed in the tumors from chronically and intermittently sun-exposed
localizations were five CGA Arg, four AAA Lys, and two CTA Leu,
all consistent with possible UV induction via the above-mentioned
primary photoproducts. The two mutation-containing tumors from
intermittently sun-exposed localizations were from patients with
recorded severe sunburn and pronounced sun-bathing behavior. Two
additional CGA Arg mutations in tumors from the vulva were obviously
induced via a mechanism other than UV induction.
No significant correlation existed between ras mutation and Breslow
thickness in this series of melanomas. Similarly, a European study of
175 primary melanomas revealed a highly significant correlation
between sun exposure and N-ras mutation, but no obvious correlation
between N-ras mutation and tumor progression as defined by Clark
level of invasion, Breslow thickness, or tendency to metastasize (van
Elsas et al, 1996). In contrast, a previous report (Ball et al, 1994)
demonstrated a significant correlation between Breslow thickness and
N-ras mutation. Analyses of larger randomized samples are needed in
order to resolve these contradictions.
Our results provide clear answers to the three questions initially
asked. First, mutations appeared exclusively in the N-ras oncogene
and consisted, with a single exception, of point mutations in codon
61. The single exception was a codon 12 mutation found in a primary
melanoma of the vulva. Second, the frequencies of N-ras codon 61
mutations were: 32% in primary melanomas from head and neck areas
with chronic sun exposure, 11% from sites with intermittent sun
exposure, and 7% from unexposed body localizations (vulva, vagina,
anus and rectum, palate). Third, the N-ras codon 61 mutations in the
melanoma examined here are consistent with known mechanisms for
UV induction.
These results strongly support the likelihood that UV light induces
N-ras codon 61 mutations in a subset of primary cutaneous melanomas
and that these mutations play a role in the early stages of melanoma
development.
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